Search details
1.
Should surgery be part of the multimodality treatment for stage IIIB non-small cell lung cancer?
J Surg Oncol
; 117(7): 1570-1574, 2018 Jun.
Article
in English
| MEDLINE | ID: mdl-29573419
2.
ERCC1 isoform expression and DNA repair in non-small-cell lung cancer.
N Engl J Med
; 368(12): 1101-10, 2013 Mar 21.
Article
in English
| MEDLINE | ID: mdl-23514287
3.
Adjuvant chemotherapy for resected early-stage non-small cell lung cancer.
Cochrane Database Syst Rev
; (3): CD011430, 2015 Mar 02.
Article
in English
| MEDLINE | ID: mdl-25730344
4.
Association of Molecular Profiles and Mutational Status With Distinct Histological Lung Adenocarcinoma Subtypes. An Analysis of the LACE-Bio Data.
Clin Lung Cancer
; 24(6): 528-540, 2023 09.
Article
in English
| MEDLINE | ID: mdl-37438216
5.
Non-small-cell lung cancer.
Lancet
; 378(9804): 1727-40, 2011 Nov 12.
Article
in English
| MEDLINE | ID: mdl-21565398
6.
WITHDRAWN: Second or third additional chemotherapy drug for non-small cell lung cancer in patients with advanced disease.
Cochrane Database Syst Rev
; (4): CD004569, 2012 Apr 18.
Article
in English
| MEDLINE | ID: mdl-22513924
7.
Prognostic and predictive effect of KRAS gene copy number and mutation status in early stage non-small cell lung cancer patients.
Transl Lung Cancer Res
; 10(2): 826-838, 2021 Feb.
Article
in English
| MEDLINE | ID: mdl-33718025
8.
Preoperative chemotherapy for non-small-cell lung cancer--authors' reply.
Lancet
; 384(9939): 233, 2014 Jul 19.
Article
in English
| MEDLINE | ID: mdl-25042232
9.
10-year long-term survival of a metastatic EGFR-mutated nonsmall cell lung cancer patient.
Eur Respir J
; 46(1): 280-2, 2015 Jul.
Article
in English
| MEDLINE | ID: mdl-25882801
10.
A Bill of Rights for patients with cancer in Europe.
Lancet Oncol
; 15(3): 258-60, 2014 Mar.
Article
in English
| MEDLINE | ID: mdl-24503530
11.
America's cancer care crisis--is Europe any better?
Lancet
; 382(9905): 1628, 2013 Nov 16.
Article
in English
| MEDLINE | ID: mdl-24238555
12.
A catalyst for change: the European cancer Patient's Bill of Rights.
Oncologist
; 19(3): 217-24, 2014 Mar.
Article
in English
| MEDLINE | ID: mdl-24493667
13.
DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy.
N Engl J Med
; 355(10): 983-91, 2006 Sep 07.
Article
in English
| MEDLINE | ID: mdl-16957145
14.
Adjuvant or induction cisplatin-based chemotherapy for operable lung cancer.
Oncology (Williston Park)
; 23(6): 520-7, 2009 May.
Article
in English
| MEDLINE | ID: mdl-19544693
15.
LACE-Bio: Validation of Predictive and/or Prognostic Immunohistochemistry/Histochemistry-based Biomarkers in Resected Non-small-cell Lung Cancer.
Clin Lung Cancer
; 20(2): 66-73.e6, 2019 03.
Article
in English
| MEDLINE | ID: mdl-30414783
16.
Multidrug resistance proteins do not predict benefit of adjuvant chemotherapy in patients with completely resected non-small cell lung cancer: International Adjuvant Lung Cancer Trial Biologic Program.
Clin Cancer Res
; 13(13): 3892-8, 2007 Jul 01.
Article
in English
| MEDLINE | ID: mdl-17606722
17.
Genome-wide copy number analyses of samples from LACE-Bio project identify novel prognostic and predictive markers in early stage non-small cell lung cancer.
Transl Lung Cancer Res
; 7(3): 416-427, 2018 Jun.
Article
in English
| MEDLINE | ID: mdl-30050779
18.
Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer.
N Engl J Med
; 350(4): 351-60, 2004 Jan 22.
Article
in English
| MEDLINE | ID: mdl-14736927
19.
Erlotinib for frontline treatment of advanced non-small cell lung cancer: a phase II study.
Clin Cancer Res
; 12(20 Pt 1): 6049-55, 2006 Oct 15.
Article
in English
| MEDLINE | ID: mdl-17062680
20.
Second or third additional chemotherapy drug for non-small cell lung cancer in patients with advanced disease.
Cochrane Database Syst Rev
; (4): CD004569, 2007 Oct 17.
Article
in English
| MEDLINE | ID: mdl-17943820